Funder: European Commission
Due Dates: April 16, 2026 (Submission deadline, single-stage full proposal)
Funding Amounts: €9,000,000–€11,000,000 per project; total topic budget €44,200,000; project duration typically 3–5 years
Summary: Supports research and innovation for the development of new vaccines against specific viral pathogens with epidemic potential, advancing candidates toward clinical deployment.